BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lu JP, Mao JQ, Li MS, Lu SL, Hu XQ, Zhu SN, Nomura S. In situ detection of TGF betas, TGF beta receptor II mRNA and telomerase activity in rat cholangiocarcinogenesis. World J Gastroenterol 2003; 9(3): 590-594 [PMID: 12632524 DOI: 10.3748/wjg.v9.i3.590]
URL: https://www.wjgnet.com/1007-9327/full/v9/i3/590.htm
Number Citing Articles
1
Laura Fouassier, Marco Marzioni, Marta B. Afonso, Steven Dooley, Kevin Gaston, Gianluigi Giannelli, Cecilia M. P. Rodrigues, Elisa Lozano, Serena Mancarella, Oreste Segatto, Javier Vaquero, Jose J. G. Marin, Cédric Coulouarn. Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistanceLiver International 2019; 39(S1): 43 doi: 10.1111/liv.14102
2
Chanitra Thuwajit, Peti Thuwajit, Pranisa Jamjantra, Chawalit Pairojkul, Sopit Wongkham, Vajarabhongsa Bhudhisawasdi, Junya Ono, Shoichiro Ohta, Kiminori Fujimoto, Kenji Izuhara. Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosisOncology Letters 2017; 14(1): 623 doi: 10.3892/ol.2017.6250
3
Wei-Guo Deng, Yan Fu, Yu-Lin Li, Toshihiro Sugiyama. Potential role of p53 mutation in chemical hepatocarcinogenesis of ratsWorld Journal of Gastroenterology 2004; 10(1): 46-52 doi: 10.3748/wjg.v10.i1.46
4
Mariateresa Giuliano, Antonietta Stellavato, Marcella Cammarota, Monica Lamberti, Nadia Miraglia, Nicola Sannolo, Mario De Rosa. Effects of low concentrations of benzene on human lung cells in vitroToxicology Letters 2009; 188(2): 130 doi: 10.1016/j.toxlet.2009.03.018
5
Alphonse E. Sirica, Catherine I. Dumur, Deanna J.W. Campbell, Jorge A. Almenara, Olorunseun O. Ogunwobi, Jennifer L. Dewitt. Intrahepatic Cholangiocarcinoma Progression: Prognostic Factors and Basic MechanismsClinical Gastroenterology and Hepatology 2009; 7(11): S68 doi: 10.1016/j.cgh.2009.08.023
6
Tetsuya Shimizu, Shigeki Yokomuro, Yoshiaki Mizuguchi, Yutaka Kawahigashi, Yasuo Arima, Nobuhiko Taniai, Yasuhiro Mamada, Hiroshi Yoshida, Koho Akimaru, Takashi Tajiri. Effect of transforming growth factor-β1 on human intrahepatic cholangiocarcinoma cell growthWorld Journal of Gastroenterology 2006; 12(39): 6316-6324 doi: 10.3748/wjg.v12.i39.6316
7
Bradley P. Sullivan, Karen M. Kassel, Sharon Manley, Alyson K. Baker, James P. Luyendyk. Regulation of Transforming Growth Factor-β1-Dependent Integrin β6 Expression by p38 Mitogen-Activated Protein Kinase in Bile Duct Epithelial CellsJournal of Pharmacology and Experimental Therapeutics 2011; 337(2): 471 doi: 10.1124/jpet.110.177337
8
Kwang Suk Ko, Hui Peng, Hua Tang, Michele E. Cho, Jian Peng, Maria-Angeles Aller, Heping Yang. Recent advances of miRNA involvement in hepatocellular carcinoma and cholangiocarcinomaOpen Journal of Internal Medicine 2012; 2(03): 135 doi: 10.4236/ojim.2012.23024
9
Jesus M. Banales, Vincenzo Cardinale, Guido Carpino, Marco Marzioni, Jesper B. Andersen, Pietro Invernizzi, Guro E. Lind, Trine Folseraas, Stuart J. Forbes, Laura Fouassier, Andreas Geier, Diego F. Calvisi, Joachim C. Mertens, Michael Trauner, Antonio Benedetti, Luca Maroni, Javier Vaquero, Rocio I. R. Macias, Chiara Raggi, Maria J. Perugorria, Eugenio Gaudio, Kirsten M. Boberg, Jose J. G. Marin, Domenico Alvaro. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)Nature Reviews Gastroenterology & Hepatology 2016; 13(5): 261 doi: 10.1038/nrgastro.2016.51
10
Wei Wang, He-Sheng Luo, Bao-Ping Yu. Expression of NF-κB and human telomerase reverse transcriptase in gastric cancer and precancerous lesionsWorld Journal of Gastroenterology 2004; 10(2): 177-181 doi: 10.3748/wjg.v10.i2.177